These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15831881)

  • 1. Switching prescription drugs to over the counter: consumers may benefit financially in examples from the US.
    Sullivan PW
    BMJ; 2005 Apr; 330(7496):904-5. PubMed ID: 15831881
    [No Abstract]   [Full Text] [Related]  

  • 2. Coupon programs curb antihistamine utilization.
    Berberabe T
    Manag Care; 2003 Aug; 12(8):28-9. PubMed ID: 12966848
    [No Abstract]   [Full Text] [Related]  

  • 3. The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines.
    Sullivan PW; Nichol MB
    Value Health; 2004; 7(4):402-12. PubMed ID: 15449632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis.
    Sullivan PW; Follin SL; Nichol MB
    Med Care; 2003 Dec; 41(12):1382-95. PubMed ID: 14668671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching prescription drugs to over the counter.
    Cohen JP; Paquette C; Cairns CP
    BMJ; 2005 Jan; 330(7481):39-41. PubMed ID: 15626806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marketing of a new non-sedating antihistamine (fexofenadine) puts an additional burden on healthcare system resources in Israel.
    Cohen AD; Vardy DA; Gan-El U; Lieberman N; Reuvni H
    Eur J Gen Pract; 2006; 12(2):77-9. PubMed ID: 16945882
    [No Abstract]   [Full Text] [Related]  

  • 7. OTC loratadine.
    Med Lett Drugs Ther; 2003 Jan; 45(1147):3-4. PubMed ID: 12515952
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy.
    Sullivan PW; Nair KV; Patel BV
    Am J Manag Care; 2005 Jun; 11(6):374-82. PubMed ID: 15974556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic and economic consequences of OTC loratadine.
    Nair KV; Sullivan PW
    Ann Pharmacother; 2004 Jan; 38(1):169-71. PubMed ID: 14742815
    [No Abstract]   [Full Text] [Related]  

  • 10. Ahh-choo! How to sneeze at allergies.
    Consum Rep; 2010 May; 75(5):7. PubMed ID: 20419895
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA approves OTC Claritin.
    FDA Consum; 2003; 37(1):3. PubMed ID: 12625285
    [No Abstract]   [Full Text] [Related]  

  • 12. Managed care implications of the approval of generic or over-the-counter nonsedating antihistamines.
    Giaquinta D
    Manag Care Interface; 2002 Jun; 15(6):31-4. PubMed ID: 12087604
    [No Abstract]   [Full Text] [Related]  

  • 13. Costs of second-generation antihistamines in the treatment of allergic rhinitis: US perspective.
    Hay JW; Kaliner MA
    Curr Med Res Opin; 2009 Jun; 25(6):1421-31. PubMed ID: 19422280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pill to be available without prescription or age restriction.
    Kouros N
    Monash Bioeth Rev; 2013 Sep; 31(2):21. PubMed ID: 24844069
    [No Abstract]   [Full Text] [Related]  

  • 15. Ugly wait at the counter. Insurer pushes to make allergy drugs nonprescription.
    Benko LB
    Mod Healthc; 2001 Aug; 31(32):22-3. PubMed ID: 11507861
    [No Abstract]   [Full Text] [Related]  

  • 16. Allergy warning.
    Underwood A
    Newsweek; 2002 Dec; 140(24):88. PubMed ID: 12500716
    [No Abstract]   [Full Text] [Related]  

  • 17. Patient, medicate thyself.
    Ortolon K
    Tex Med; 2003 Nov; 99(11):43-6. PubMed ID: 14650719
    [No Abstract]   [Full Text] [Related]  

  • 18. Switching prescription drugs to over the counter: over the counter licensing is linked to direct to consumer advertising.
    Bunney RG
    BMJ; 2005 Apr; 330(7496):906. PubMed ID: 15831890
    [No Abstract]   [Full Text] [Related]  

  • 19. Over-the-counter drugs as a new managed care benefit.
    Scheur BS; Aaron RM
    Med Interface; 1997 Feb; 10(2):88-94. PubMed ID: 10164797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefits of switching smoking cessation drugs to over-the-counter status.
    Keeler TE; Hu TW; Keith A; Manning R; Marciniak MD; Ong M; Sung HY
    Health Econ; 2002 Jul; 11(5):389-402. PubMed ID: 12112489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.